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Strengths and limitations of this study
 ► This is the first study to look at the use of wear-
able accelerometers to measure and characterise 
physical activity in high- risk elderly patients in the 
preoperative period.
 ► We present a robust and objective method of mea-
suring physical activity levels and compared this 
to self- reporting methods of measuring physical 
activity.
 ► We were able to assess the impact of an exist-
ing unoptimised preoperative intervention using 
accelerometery.
 ► Limitations of this study include small sample size 
although this is justified by the fact that it was an 
initial pilot study to establish normative physical ac-
tivity and acceptability data to facilitate power cal-
culations for further studies.
AbStrACt
Objectives To use wrist- worn accelerometers (Axivity 
AX3) to establish normative physical activity (PA) and 
acceptability data for the high- risk elderly preoperative 
population, to assess whether PA could be modified by 
a prehabilitation intervention as part of routine care, 
to assess any correlation between accelerometer- 
measured PA and self- reported PA and to assess the 
acceptability of wearing wrist- worn accelerometers in 
this population.
Study design Prospective, observational, pilot study.
Setting Single National Health Service Hospital.
Participants Frail patients≥65 years awaiting major 
surgery referred to a multidisciplinary preoperative clinic 
at which they received a routine intervention aimed at 
improving their PA. 35 patients were recruited. Average 
age 79.9 years (SD=5.6).
Primary outcomes Normative PA data measured as a 
mean daily Euclidean norm minus one (ENMO) in milli- 
gravitational units (mg).
Secondary outcomes Measure PA levels (mg) following 
a routine preoperative intervention. Determine correlation 
between patient- reported PA (measured using the Physical 
Activity Scale for the Elderly) and accelerometer- measured 
PA (mg). Assess acceptability of wearing a wrist- worn 
accelerometer measured using Visual Analogue Scale 
(VAS) questionnaire and device wear time (hours).
results Median baseline daily PA was 14.3 mg (IQR 
9.75–22.04) with an improvement in PA detected 
following the intervention (median ENMO post intervention 
20.91 mg (IQR 14.83–27.53), p=0.022). There was no 
significant correlation between accelerometer- measured 
and self- reported PA (baseline ρ=0.162 (p=0.4), 
post intervention ρ=−0.144 (p=0.5)). We found high 
acceptability ratings (median score of 10/10 on VAS, IQR 
8–10) and wear- time compliance (163.2 hours (IQR 150–
167.5) preintervention and 166.1 hours (IQR 162.5–167) 
post intervention).
Conclusions Accelerometery is acceptable to this 
population and increases in PA levels measured following 
an unoptimised routine clinical intervention which 
indicates that health behavioural change interventions 
may be successful during the preoperative period. 
Accelerometers may therefore be a useful tool to design 
and validate interventions for improving PA in this setting.
trial registration number NCT03737903.
IntrOduCtIOn
The ‘high- risk’ surgical population is charac-
terised by advanced age, frailty and multiple 
comorbidities particularly when undergoing 
major surgery. This population accounts for 
just 12.5% of surgical procedures, but over 
80% of perioperative deaths in the UK.1 With 
an ageing population, increasing numbers of 
high- risk patients require surgery. It is there-
fore important to improve our understanding 
of risk factors for perioperative complications 
in order to facilitate shared decision- making 
and appropriate planning of perioperative 
care.
Frailty status is an independent predictor 
of postoperative morbidity and mortality2 3 
and physical inactivity is a defining feature of 
frailty. Older adults spend a significant part of 
their day being sedentary4 and do not meet 
current physical activity (PA) recommenda-
tions.5 6 Increased PA can slow progression to 
a frail state7 and there is growing evidence for 
the positive association between preoperative 
PA and perioperative outcomes.8 Prehabilita-
tion programmes incorporate optimisation 
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of medical, nutritional and psychological status alongside 
prescribed exercise training programmes with specific 
goals of muscle strengthening and increased physical 
fitness, but are labour intensive and most have subop-
timal participant adherence rates.9 PA may also be an 
attractive prehabilitation target although it is currently 
not known whether improving PA is feasible or leads to 
improvements in outcome.
Sustained changes in habitual, environmentally cued 
health behaviours are notoriously difficult to achieve,10 
but it is plausible that the preoperative period, due to the 
well- defined target endpoint (surgery), may represent 
a unique teachable moment during which motivation 
to convert intention into action may be elevated, and a 
sustained change in behaviour may be more achievable 
than other settings. Thus, it may be possible to influence 
patient behaviours in order to reduce perioperative risk 
and improve outcomes.
Since the high- risk surgical group is likely to differ 
from the general population, normative PA data and 
patient acceptability data are lacking and this needs to 
be established before targeted intervention studies can be 
designed. To this end, it is critical to first have a robust, 
precise method of measuring PA and to understand PA 
related to daily routine in order to establish a baseline 
against which the impact of future interventions could 
be measured. Traditionally, in the perioperative setting, 
patients’ PA levels have been evaluated using brief self- 
report questionnaires; however, these are prone to error 
and recall bias.11 The gold standard method of direct 
observation is labour intensive and time consuming, and 
therefore not feasible for widespread use.12 Accelerome-
ters could offer a potential solution; triaxial accelerome-
ters detect magnitude and direction of acceleration and 
have been used in large- scale epidemiological studies to 
provide a valid estimate of overall PA.13 They are unobtru-
sive and non- invasive and can measure PA in free- living 
environments and may offer a means to assess the effi-
cacy and therefore optimise interventions to improve 
PA. However, this first requires the specific population of 
interest to be characterised. Although wrist- worn accel-
erometery has been validated to measure PA in older 
patients,13 to our knowledge wearable accelerometers 
have not previously been used to characterise PA in a 
high- risk elderly population in the preoperative period. 
Furthermore, the acceptability of PA measurement has 
not been established in these patients.
Through this pilot study, we aimed to characterise PA 
levels in relation to daily routine across a variety of surgical 
specialties in order to obtain normative data to inform 
sample size calculations for future intervention studies. 
We also sought to assess whether there was a change in PA 
following current preoperative interventions (which form 
part of usual care in our centre) and quantify the vari-
ability of that change. We set out to quantify the correla-
tion between objectively measured and self- reported PA 
in this patient group. Finally, as accelerometers have not 
previously been used in this setting, we aimed to assess 
how acceptable it is to use wrist- worn accelerometers to 
measure PA in high- risk elderly patients in the preoper-
ative period prior to rolling them out into a larger scale 
programme of research.
MethOdS
Study approvals and population
This study was conducted at Cambridge University Hospi-
tals National Health Service (NHS) Foundation Trust. 
Written informed consent was obtained from all partic-
ipants. All patients awaiting high- risk surgery are seen 
in a nurse- led preoperative assessment clinic (outpa-
tient setting) as part of routine care, at which point they 
undergo frailty screening and may be referred to the 
‘perioperative review informing management of elderly 
patients’ (PRIME) clinic (a multidisciplinary clinic specif-
ically designed to optimise frail elderly patients preop-
eratively). Inclusion criteria for this study were patients 
referred to the PRIME clinic, participants must have had 
capacity to consent and complete activity questionnaires 
and be willing and able to wear the accelerometer around 
their wrist. PRIME clinic referral criteria were patients 
listed for major or complex surgery who were aged ≥65 
years and either had a Rockwood Clinical Frailty Scale14 
score (CFS) of ≥4 or had a clinical picture that gave the 
preassessment nurse enough concern to refer for a multi-
disciplinary preoperative assessment. Referral to, and 
attendance at the PRIME clinic formed part of usual 
preoperative care at our institution. Participants were 
excluded from the study if they did not meet the inclusion 
criteria, they refused to participate or their PRIME clinic 
appointment was scheduled <72 hours after referral for 
recruitment, as previous research has shown a minimum 
period of 72 hours of continuous accelerometer wear 
time is required to produce valid data.13 Recruitment 
took place between July and December 2018.
Patient and public involvement
Patient and public involvement (PPI) was sought during 
the study design process with the aim of ensuring that 
the research question was agreed to be important, the 
methods and running of the study were likely to be accept-
able to patients and the documents were written appro-
priately for the target study population. Study documents 
including patient information leaflets, consent forms 
and information posters were circulated to Cambridge 
University Hospital PPI panel for review. Feedback from 
the PPI panel allowed us to construct more lay- friendly 
documents. The PPI panel considered the burden of 
intervention and time required to participate in research. 
We will consider further PPI involvement in order to 
disseminate the study results to those participants who 
requested to be informed.
Accelerometer and data collection
Participants wore a waterproof triaxial accelerometer 
(Axivity AX3, Newcastle, UK15) which has been used 
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in other studies of functionally impaired people.16 The 
device was worn around the wrist for 24 hours per day, for 
7 days prior to their PRIME clinic visit and 7 days immedi-
ately after their PRIME clinic visit. Participants wore the 
device around their preferred wrist for convenience and 
to maximise compliance. Participants were instructed by 
the research team how to refit the accelerometer should 
they remove it for any reason. Accelerometer devices were 
programmed to commence data collection on the same 
day that the device was fitted and to record for 7 days. 
The accelerometer measures acceleration in three axes 
sampled at 100 Hz with a dynamic range of ±8 g.
Raw accelerometery data were downloaded and visu-
ally inspected in order to detect any accelerometer tech-
nical issues, to ensure that the accelerometer was worn 
and recorded for the correct duration and had recorded 
the signals as expected. Data analyses were performed in 
R- package GGIR, the details of which have been previ-
ously described.17
PA- related acceleration was calculated using autocali-
brated Euclidian norm minus one (ENMO).18 The values 
presented are the average ENMO for all of the available 
data normalised per 24 hours cycle (diurnally balanced), 
with invalid data imputed using the average at similar 
time points on different days of the week. We chose to use 
ENMO as our measure of PA since previously published 
cut- offs for mild/moderate/vigorous intensity PA may 
not apply to this patient population.
The PRIME clinic visit involves a preoperative review 
by an anaesthetist, geriatrician, physiotherapist and occu-
pational therapist. During this clinic visit, patients were 
provided with a behavioural change intervention as part 
of usual perioperative care at our institution (see the 
Behavioural change intervention section). At the PRIME 
clinic visit, a member of the research team retrieved the 
accelerometer worn by participants for the initial 7- day 
period and provided the participant with a new device 
for the second 7- day period. Participants completed two 
questionnaires at the PRIME clinic visit: a validated self- 
reported activity questionnaire; Physical Activity Scale 
for the Elderly (PASE),19 and a locally designed accept-
ability questionnaire (see the Assessment of acceptability 
section). Participants were asked to repeat the PASE ques-
tionnaire at the end of the second 7- day wear period and 
return the accelerometer and completed PASE question-
naire back to the study centre in a prepaid envelope.
Assessment of acceptability
Overall acceptability was assessed using a participant 
completed questionnaire using a Visual Analogue Scale 
from 0 to 10, 0 being ‘very unacceptable’ and 10 being 
‘very acceptable’. We also measured the length of time that 
the devices were worn in hours (wear- time compliance).
behavioural change intervention (PrIMe clinic visit)
The behavioural change intervention (given as part of 
usual care) consisted of PA and exercise advice described 
as follows according to the template for intervention 
description and replication checklist.20 The goals of the 
intervention were to improve PA levels on a day- to- day 
basis through activities of daily living (ADLs) or leisure 
activities, to improve specific aspects of fitness, periopera-
tive respiratory function and promote independence with 
personal and domestic ADLs and leisure activities. Verbal 
and written advice was provided as follows: two generic 
exercise leaflets (general exercises for the whole body, 
and walking exercises), bespoke exercise programmes 
(generated using online Physiotools21 software) and local 
hospital- specific respiratory exercise information leaflets 
were provided along with advice and information about 
appropriate community services. The intervention was 
administered by an NHS band seven physiotherapist with 
a background in surgery and elderly rehabilitation and 
an NHS band seven occupational therapist with a back-
ground in surgery, orthopaedics and elderly rehabilita-
tion via one face- to- face session (PRIME clinic visit) lasting 
40 min. The information described above was given to 
participants in the PRIME clinic room with the expec-
tation that they would undertake the activities in their 
own homes. The intervention was tailored to each partic-
ipant, depending on presentation and planned surgical 
procedure. Advice given to participants was decided 
by experienced clinicians in the PRIME clinic and was 
based on their clinical judgement following a compre-
hensive assessment. Personalised exercise programmes 
were designed by the physiotherapist during the clinic 
visit and taught to participants during this session, with a 
written information leaflet given to the participant to take 
home. Adherence to this intervention was not otherwise 
assessed.
Statistical analysis
We generated descriptive statistics for the number of 
participants, wear time in hours and average daily ENMO 
milligravitational units (mg). We analysed the difference 
in ENMO before and after the existing intervention using 
the Wilcoxon signed rank test. We also analysed ENMO 
stratified into orthopaedic and non- orthopaedic surgical 
populations.
Since accelerometery and self- reported PA (measured 
using PASE) are continuous variable, we analysed correla-
tion using the Pearson correlation coefficient.
Statistical analysis was conducted using the R statistical 
language.22 Mixed- effect models were constructed using 
the lme4 package23; significance testing was done using 
analysis of deviance. A statistical significance level of 5% 
was assumed throughout and no correction for multiple 
comparisons was made.
reSultS
Thirty- six patients were invited to take part in the study, 
of which 35 participants were recruited, 19 (54%) were 
women. Twenty participants (57%) were listed for ortho-
paedic surgery, 7 (20%) gastrointestinal surgery, 5 (14%) 
urological surgery and 1 each for vascular, gynaecology 
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Table 1 Characteristics of the study population, values are 
mean (SD), number (proportion)
Characteristics of study sample (n=35) Value
Age; years 79.9 (5.6)
Sex
  Female 19 (54%)
  Male 16 (46%)
Rockwood Clinical Frailty Score
  3 1 (2.9%)
  4 12 (34.3%)
  5 17 (48.6%)
  6 5 (14.3%)
Surgical specialty
  Orthopaedic 20 (57%)
  Gastrointestinal 7 (20%)
  Urology 5 (14%)
  Gynaecology 1 (3%)
  Vascular 1 (3%)
  Breast 1 (3%)
ASA score*
  2 8 (23%)
  3 27 (77%)
*ASA, American Society of Anaesthesiologists physical status 
classification system score.
Figure 1 Notched box plots representing physical activity 
(Euclidian norm minus one (ENMO), milligravitational units 
mg) before (blue) and after (red) the perioperative review 
informing management of elderly patients (PRIME) clinic 
intervention in all participants (left), participants listed 
for orthopaedic surgery (middle) and non- orthopaedic 
surgery (right). Open circle (o) represents outliers. The 
notch represents the 95% CI of the median; 95% CI that 
the medians differ if two boxes’ notches do not overlap. 
Significant differences between ‘before-’, and ‘after-’ 
intervention groups are indicated with an asterisk (*).
and breast surgery. The mean age was 79.9 years (SD=5.6 
years). Characteristics of the study population are given 
in table 1. Our study was not powered to fully define 
the spectrum of comorbidities in this group. Instead, 
we summarised physical status in terms of the American 
Society of Anaesthesiologists physical status classification 
score which is widely used for perioperative risk assess-
ment. Median nurse- assessed Rockwood CFS was 5 (IQR 
4–5).
Accelerometery data were available for analysis for 34 
participants before the intervention and 30 participants 
after the intervention. Data from one preintervention 
participant were unavailable due to an accelerometer 
programming error, and three participants were with-
drawn from the postintervention part of the study because 
their surgical procedure was scheduled to be <72 hours 
after the PRIME clinic visit; thus, participants would 
not have been able to wear the device for the minimum 
required time of 72 hours. One participant was with-
drawn from the postintervention part of the study due 
to skin irritation around the wrist strap (notably similar 
irritation was also caused by their own wristwatch), and 
one participant was withdrawn due to an area of bruising 
around the wrist strap. This participant was taking oral 
anticoagulants.
Preoperative baseline PA levels were obtained in 34 
participants. The median baseline daily PA level was 
14.3 mg (IQR 9.75–22.04). There was no significant 
difference in baseline median PA between men (12.6 mg 
(IQR 9.5–15.7)), and women (16.9 mg (IQR 12.5–23.9)), 
p=0.18). Median baseline daily PA in orthopaedic patients 
was 15.3 mg (IQR 10.1–23.5), compared with a median 
of 12.7 mg (IQR 9.2–16.6) in non- orthopaedic patients 
(p=0.271) as shown in figure 1. Baseline PA was higher in 
women than men in this orthopaedic subgroup (22.84 mg 
vs 10.17 mg, p=0.046).
There was a significant increase in overall daily ENMO 
after the standard clinical intervention (median base-
line ENMO 14.3 mg (IQR 9.75–22.04), median ENMO 
postintervention 20.91 mg (IQR 14.83–27.53), p=0.022) 
as shown in figure 1. There was no significant difference 
in ENMO before and after the intervention in patients 
awaiting orthopaedic surgery (median baseline ENMO 
15.29 mg (IQR 10.07–23.5), median ENMO postinter-
vention 20.05 mg (IQR 14.83–27.61), p=0.304). However, 
in those participants listed for non- orthopaedic surgery, 
there was a significant increase in mean PA following the 
intervention (median baseline ENMO 12.71 mg (IQR 
9.20–16.61), median ENMO post intervention 21.49 mg 
(IQR 18.04–25.82), p=0.019); see figure 1.
The distribution of PA over time for all patients is 
shown in figure 2 for both preintervention and postinter-
vention. There was evidence for a linear increase (mixed- 
effect model) in PA over time in the preintervention 
group +0.28 mg/day (95% CI 0.011 to 0.53, p=0.04) with 
a similar finding in the postintervention group +0.15 mg/
day (95% CI −0.19 to 0.50, p=0.37), although not achieving 
statistical significance. There was no evidence for a signifi-
cant effect of whether the day was a weekend or not, nor 
was there evidence for a nonlinear time dependency.
There was no significant difference in self- reported 
PASE scores before and after the PRIME clinic inter-
vention (median PASE preintervention was 67 (IQR 
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Figure 2 Physical activity (ENMO) against time before (left 
panel) and after (right panel) the intervention for each patient. 
The dots/blue lines represent the mean across the patient 
group with ±1 SD shaded. Only complete (2–6) days included. 
Mean physical activity is increased after the intervention with 
no discernible decline in activity over time.
31–89.75), median PASE postintervention was 65 (IQR 
45.5–101) p=0.247). Furthermore, no significant statis-
tical correlation was found between the accelerometer- 
measured PA and the self- reported PA measured using 
the PASE questionnaire, either before or after the inter-
vention (baseline ρ=0.162 (p=0.4), postintervention 
ρ=−0.144 (p=0.5)).
The median wear time of the wrist- worn accelerom-
eter was 163.2 hours (IQR 150–167.5) preintervention 
and 166.1 hours (IQR 162.5–167) postintervention. On 
average, participants wore the accelerometers for 98% of 
the measurement period indicating excellent wear- time 
compliance, with values comparable to those achieved 
in other studies.13 Thirty- three participants completed 
the acceptability questionnaire, and the median overall 
acceptability score obtained was 10 (IQR 8–10). The high 
wear- time compliance, low voluntary withdrawal rate and 
high acceptability scores indicate overall acceptability and 
feasibility of measuring PA in high- risk elderly patients in 
the preoperative period using these accelerometers.
dISCuSSIOn
These data demonstrate that wrist- worn accelerometers 
can successfully be used to measure PA in high- risk elderly 
patients in the preoperative period, and that this process 
was acceptable to participants. The fact that there was no 
statistical correlation between participant- reported PASE 
and accelerometer- measured PA highlights the need for 
more objective measures of PA24 and suggests a role for 
such devices in perioperative research and perhaps clin-
ical care.
We demonstrated a substantial variability in baseline 
PA in the frail elderly preoperative population. Our study 
also gives an estimate of the typical mean daily PA levels 
in this specific group of patients which has not previously 
been described. Such data should inform the planning 
of potential studies involving PA measurements in this 
setting. We found low PA levels in this population: we 
do not have access to a ‘control’ group as such a group 
would be difficult to define. However, by way of compar-
ison, the UK Biobank study reported mean daily ENMO 
values in over three thousand 75–79 year olds (the most 
comparable group to ours) women of 23.9 mg (SD=6.5) 
and in men this was 22.9 mg (SD=6.8).13 Our study popu-
lation had lower baseline mean daily ENMO of 18.9 mg 
(SD=10.5) in women, and 13.71 mg (SD=6.1) in men, 
which may reflect their underlying medical conditions, 
frailty and increased age (mean age of our study popula-
tion was 79.9 years SD 5.6).
ENMO may not be as intuitive as postprocessed PA 
intensity metrics such as step count or time spent in 
various intensities of PA. However, such metrics may not 
generalise outside the population in which they were 
developed.25 Furthermore, we wanted to avoid using any 
potentially proprietary algorithms. Using unprocessed 
ENMO avoids both of these problems as it is the funda-
mental physical quantity measured by all accelerome-
ters and should therefore be agnostic to patient group. 
Further work is be needed to develop metabolically 
meaningful PA intensity cut points in this patient group, 
but we suggest from our work that ENMO summary data 
are a useful surrogate even without this.
In the non- orthopaedic subgroup, we found a signifi-
cant increase in PA following the PRIME clinic interven-
tion, even though this was not optimised. Mixed- effect 
modelling did not show any decrease in PA over time 
in either the preintervention or postintervention group 
suggesting that PA levels were sustained at least for the 
duration of the measurement period. Because we had no 
control on which day of the week participants would be 
recruited from clinic, we also looked at whether activity 
might be different on weekend days, but this did not 
seem to be the case in this population. The PA levels in 
some patients postintervention resembled more closely 
the baseline levels reported in the Biobank study. The 
fact that PA levels increased to this extent following the 
unoptimised intervention is a remarkable and some-
what unexpected finding as health behavioural change 
is notoriously difficult to achieve.10 Our findings provide 
some evidence to suggest that the preoperative setting 
may indeed represent a unique period during which 
behavioural interventions are more likely to result in 
improvements in PA, perhaps due to the well- defined 
endpoint (surgical procedure) and the motivation that 
PA may impact perioperative outcome. It seems reason-
able to suggest that a well- designed complex intervention 
could result in greater changes in PA.
The lack of significant improvement in PA in those 
participants awaiting orthopaedic surgery may indicate a 
restriction of PA in this population, in which mobility is 
likely to be limited due to underlying orthopaedic prob-
lems (all orthopaedic participants were awaiting major 
lower limb joint replacements). The potential to increase 
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preoperative PA in the orthopaedic population may be 
limited; waiting lists for joint replacement surgery in the 
UK are long, and such patients may have already been in 
the hospital system prior to the PRIME clinic visit (inter-
vention). This potentially restricted PA, and prior engage-
ment with hospital services may mean that these patients 
may have already received PA advice from their surgical 
and primary care teams prior to referral to the PRIME 
clinic and may have already reached their prehabilita-
tion limit. Nevertheless, although PA in this subgroup 
group did not change following the existing unoptimised 
intervention, there is perhaps still scope for a better 
intervention, and wearable accelerometers may assist 
in determining what this may be. Our finding provides 
support for the idea that a complex intervention would 
need to be tailored to this population.
We asked participants to wear the accelerometers 
around their wrist. Traditionally, the hip has been the 
most widely used site for placement of the accelerom-
eter as this was believed to best represent total body 
movement.26 However, wear- time compliance has been a 
problem with hip- worn devices which limits the validity 
of the data analysis.27 Cui et al28 fixed an accelerometer 
to participants’ chests using an adhesive plaster; however, 
one quarter of participants did not wear the device for 
72 hours which may limit the validity of data. We opted 
for a wrist- worn device to circumvent this issue, and asked 
participants to wear the device continuously (day and 
night) for a 7- day period to simplify proceedings. We 
also felt that this placement would capture PA associated 
with ADL, likely to form a significant proportion of PA 
among a high- risk elderly population. While previous 
studies have used the non- dominant wrist,13 for this pilot 
study we allowed a pragmatic approach to allow partici-
pants to select their preferred wrist in order to maximise 
compliance and total wear time. Furthermore, previous 
work has shown no difference in PA measurements when 
measured simultaneously on the dominant and non- 
dominant wrist.29 We accept that in a frail elderly popula-
tion, many of whom use walking aids, a wrist- worn device 
must be used with caution and further work is warranted 
to evaluate the transferability of data from different sites.
Limitations of this study include the small sample size. 
Within this small sample, we were non- selective regarding 
recruitment of participants from various surgical special-
ties. As such, we were unable to further analyse data 
from subgroups other than orthopaedics versus non- 
orthopaedics. This is an area of potential future research 
incorporating larger patient numbers in various subspe-
cialties. One further limitation was that we did not attempt 
to relate ENMO measurements to specific ADL. This will 
be an important subsequent study but was outside the 
scope of this work as it might have reduced tolerability.
While we have demonstrated that patients’ behaviour 
can change in the preoperative period, we do not know 
how this translates clinically, and indeed what degree 
(if any) of change in PA might lead to a change in the 
outcomes that are important to patients. However, it is 
reasonable to propose that such a relationship might 
exist, and further work is needed to investigate whether 
increasing PA levels in the preoperative period has any 
impact on perioperative outcome, and if so, whether the 
response is dose or timing dependent. Furthermore, if 
an association between preoperative PA and periopera-
tive outcome is discovered, it is important to determine 
the minimum duration of increased PA levels required 
to influence patient outcome, and whether this would be 
feasible in the preoperative period. If optimum PA level 
targets can be determined, it would then be important to 
find out whether it is actually possible to meet PA ‘targets’ 
in the high- risk elderly population by use of preoperative 
interventions. Further research into the optimum preha-
bilitation programme for frail elderly patients in various 
patient cohorts is also required. While we have demon-
strated that the increase in PA after the intervention was 
sustained throughout the 7- day measurement period, 
we do not know whether the increase in PA is sustained 
beyond this period. Further work is required to elucidate 
this.
COnCluSIOn
Using wrist- worn accelerometers to characterise daily 
typical activity levels and assess the impact of an existing 
clinical intervention was feasible and acceptable in this 
patient population. An increase in PA levels was measured 
following an unoptimised routine clinical intervention, 
and this increase in PA was sustained for at least a week 
suggesting that the preoperative period may be a teach-
able moment in which health behavioural change inter-
ventions may be successful. Patient- reported PA did not 
correlate with our objective measurements. Accelerome-
ters may therefore be a useful tool to design and validate 
interventions for improving PA in this setting.
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